Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drugging the Undruggable: Advances on RAS Targeting in Cancer
Míriam Molina‐Arcas, Amit Samani, Julian Downward
Genes (2021) Vol. 12, Iss. 6, pp. 899-899
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Therapeutic KRAS G12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers
Edurne Mugarza, Febe van Maldegem, Jesse Boumelha, et al.
Science Advances (2022) Vol. 8, Iss. 29
Open Access | Times Cited: 86
KRAS is vulnerable to reversible switch-II pocket engagement in cells
James D. Vasta, D. Matthew Peacock, Qinheng Zheng, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 6, pp. 596-604
Open Access | Times Cited: 75
Dynamic regulation of RAS and RAS signaling
Walter Kölch, Dénes Berta, Edina Rosta
Biochemical Journal (2023) Vol. 480, Iss. 1, pp. 1-23
Open Access | Times Cited: 53
Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
E O'Sullivan, Anna Keogh, Brian E. Henderson, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1635-1635
Open Access | Times Cited: 45
Combinatorial strategies to target RAS-driven cancers
Naiara Perurena, Lisa Situ, Karen Cichowski
Nature reviews. Cancer (2024) Vol. 24, Iss. 5, pp. 316-337
Closed Access | Times Cited: 22
Recent Advances in Peptide Inhibitors Targeting Wild-Type Ras Protein Interactions in Cancer Therapy
Weirong Qin, Zijian Liu, Mingyu Huang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1425-1425
Open Access | Times Cited: 2
The Importance of Being PI3K in the RAS Signaling Network
Cristina Cuesta, Cristina Arévalo-Alameda, Esther Castellano
Genes (2021) Vol. 12, Iss. 7, pp. 1094-1094
Open Access | Times Cited: 68
Discovery of the First-in-Class Agonist-Based SOS1 PROTACs Effective in Human Cancer Cells Harboring Various KRAS Mutations
Chuan Zhou, Zisheng Fan, Zehui Zhou, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 5, pp. 3923-3942
Closed Access | Times Cited: 55
Kras oncogene ablation prevents resistance in advanced lung adenocarcinomas
Marina Salmón, Ruth Álvarez, Coral Fustero‐Torre, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 7
Open Access | Times Cited: 33
Targeting the RAS upstream and downstream signaling pathway for Cancer treatment
Md. Arafat Hossain
European Journal of Pharmacology (2024) Vol. 979, pp. 176727-176727
Closed Access | Times Cited: 13
Update on the Diagnosis and Management of Medullary Thyroid Cancer: What Has Changed in Recent Years?
Krzysztof Kaliszewski, Maksymilian Ludwig, Bartłomiej Ludwig, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3643-3643
Open Access | Times Cited: 34
Recent progress in targeting KRAS mutant cancers with covalent G12C-specific inhibitors
Lala S. Rathod, Pratap S. Dabhade, Santosh N. Mokale
Drug Discovery Today (2023) Vol. 28, Iss. 5, pp. 103557-103557
Closed Access | Times Cited: 18
Hacking Pancreatic Cancer: Present and Future of Personalized Medicine
Alessandro Di Federico, Valentina Tateo, Claudia Parisi, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 677-677
Open Access | Times Cited: 39
Targeting KRAS mutant lung cancer: light at the end of the tunnel
Matthias Drosten, Mariano Barbacid
Molecular Oncology (2021) Vol. 16, Iss. 5, pp. 1057-1071
Open Access | Times Cited: 38
Identification of New KRAS G12D Inhibitors through Computer-Aided Drug Discovery Methods
Apoorva Kulkarni, Vikas Kumar, Shraddha Parate, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1309-1309
Open Access | Times Cited: 22
RAS nanoclusters are cell surface transducers that convert extracellular stimuli to intracellular signalling
Yong Zhou, John F. Hancock
FEBS Letters (2023) Vol. 597, Iss. 6, pp. 892-908
Open Access | Times Cited: 13
Rat Sarcoma Virus Family Genes in Acute Myeloid Leukemia: Pathogenetic and Clinical Implications
Shaimaa Khattab, Adriatik Berisha, Natalia Baran, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 202-202
Open Access
Cyclic nucleotide phosphodiesterases as drug targets
Michy P. Kelly, Viacheslav O. Nikolaev, Leila Gobejishvili, et al.
Pharmacological Reviews (2025) Vol. 77, Iss. 3, pp. 100042-100042
Open Access
Identification of a lysosome-related prognostic signature to predict prognosis, tumor microenvironment and therapeutic responses in lung adenocarcinoma
Junrong Yan, Liu Ze-yuan, Xinchen Sun, et al.
Clinical Cancer Bulletin (2025) Vol. 4, Iss. 1
Open Access
Advances in the treatment of KRASG12C mutant non–small cell lung cancer
Khvaramze Shaverdashvili, Timothy F. Burns
Cancer (2025) Vol. 131, Iss. S1
Open Access
Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers
Husain Yar Khan, Misako Nagasaka, Yiwei Li, et al.
Cancer Research Communications (2022) Vol. 2, Iss. 5, pp. 342-352
Open Access | Times Cited: 20
Non-conducting functions of ion channels: The case of integrin-ion channel complexes
Elena Forzisi, Federico Sesti
Channels (2022) Vol. 16, Iss. 1, pp. 185-197
Open Access | Times Cited: 20
Update on Targeted Therapy in Medullary Thyroid Cancer
Christian Okafor, Julie Hogan, Margarita Raygada, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 23
The K-Ras(G12D)-inhibitory peptide KS-58 suppresses growth of murine CT26 colorectal cancer cell-derived tumors
Kotaro Sakamoto, Bangzhong Lin, Kazuto Nunomura, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Markov State Models Reconcile Conformational Plasticity of GTPase with Its Substrate Binding Event
Bhupendra R. Dandekar, Navjeet Ahalawat, Suman Sinha, et al.
JACS Au (2023) Vol. 3, Iss. 6, pp. 1728-1741
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top